Risk-conferring HLA variants in an epilepsy cohort: benefits of multifaceted use of whole genome sequencing in clinical practice.

Autor:	Vakrinou, Angeliki, Bellampalli, Ravishankara, Gulcebi, Medine I., Custodio, Helena Martins, Balestrini, Simona, Sisodiya, Sanjay M.
Předmět:	EPILEPSY WHOLE genome sequencing DRUG side effects HEALTH systems agencies MEDICAL genetics GENETIC testing
Zdroj:	Journal of Neurology, Neurosurgery & Psychiatry; Nov2023, Vol. 94 Issue 11, p887-892, 6p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu